Macular impairment in mitochondrial diseases: a potential biomarker of disease severity

Abstract The high-energy demands of the retina are thought to contribute to its particular vulnerability to mitochondrial dysfunction. Photoreceptors are the cells with the higher oxygen consumption within the retina, and among these, the cones contain more mitochondria and have a higher energy dema...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Guido Primiano, Edoardo Abed, Giovanni Corbo, Angelo Maria Minnella, Serenella Servidei, Catello Vollono, Maria Cristina Savastano, Benedetto Falsini
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4f4f28862fa740eca17e7a2f8390f36f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4f4f28862fa740eca17e7a2f8390f36f
record_format dspace
spelling oai:doaj.org-article:4f4f28862fa740eca17e7a2f8390f36f2021-12-02T14:58:53ZMacular impairment in mitochondrial diseases: a potential biomarker of disease severity10.1038/s41598-020-65482-32045-2322https://doaj.org/article/4f4f28862fa740eca17e7a2f8390f36f2020-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-65482-3https://doaj.org/toc/2045-2322Abstract The high-energy demands of the retina are thought to contribute to its particular vulnerability to mitochondrial dysfunction. Photoreceptors are the cells with the higher oxygen consumption within the retina, and among these, the cones contain more mitochondria and have a higher energy demand than rods. A cohort of twenty-two patients with genetically-defined mitochondrial diseases (MDs) were enrolled to determine if the macula is functionally and anatomically impaired in these metabolic disorders. Visual acuity and fERG amplitude of patients with primary mitochondrial dysfunction were reduced compared to controls. Furthermore, SD-OCT layer segmentation showed a reduction of retinal and outer nuclear layer (ONL) volume in the macula of the patients. fERG amplitude showed a positive correlation with both ONL volume and thickness. A negative relationship was noted between fERG amplitude and disease severity assessed with Newcastle Mitochondrial Disease Adult Scale. In conclusion, MDs are associated with functional and anatomical alteration of macular cone system, characterized by its strong correlation with clinical disease severity suggesting a role as a potential biomarker of primary mitochondrial disorders.Guido PrimianoEdoardo AbedGiovanni CorboAngelo Maria MinnellaSerenella ServideiCatello VollonoMaria Cristina SavastanoBenedetto FalsiniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-7 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Guido Primiano
Edoardo Abed
Giovanni Corbo
Angelo Maria Minnella
Serenella Servidei
Catello Vollono
Maria Cristina Savastano
Benedetto Falsini
Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
description Abstract The high-energy demands of the retina are thought to contribute to its particular vulnerability to mitochondrial dysfunction. Photoreceptors are the cells with the higher oxygen consumption within the retina, and among these, the cones contain more mitochondria and have a higher energy demand than rods. A cohort of twenty-two patients with genetically-defined mitochondrial diseases (MDs) were enrolled to determine if the macula is functionally and anatomically impaired in these metabolic disorders. Visual acuity and fERG amplitude of patients with primary mitochondrial dysfunction were reduced compared to controls. Furthermore, SD-OCT layer segmentation showed a reduction of retinal and outer nuclear layer (ONL) volume in the macula of the patients. fERG amplitude showed a positive correlation with both ONL volume and thickness. A negative relationship was noted between fERG amplitude and disease severity assessed with Newcastle Mitochondrial Disease Adult Scale. In conclusion, MDs are associated with functional and anatomical alteration of macular cone system, characterized by its strong correlation with clinical disease severity suggesting a role as a potential biomarker of primary mitochondrial disorders.
format article
author Guido Primiano
Edoardo Abed
Giovanni Corbo
Angelo Maria Minnella
Serenella Servidei
Catello Vollono
Maria Cristina Savastano
Benedetto Falsini
author_facet Guido Primiano
Edoardo Abed
Giovanni Corbo
Angelo Maria Minnella
Serenella Servidei
Catello Vollono
Maria Cristina Savastano
Benedetto Falsini
author_sort Guido Primiano
title Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
title_short Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
title_full Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
title_fullStr Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
title_full_unstemmed Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
title_sort macular impairment in mitochondrial diseases: a potential biomarker of disease severity
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/4f4f28862fa740eca17e7a2f8390f36f
work_keys_str_mv AT guidoprimiano macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT edoardoabed macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT giovannicorbo macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT angelomariaminnella macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT serenellaservidei macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT catellovollono macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT mariacristinasavastano macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT benedettofalsini macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
_version_ 1718389199423406080